Latest DAFNA Capital Management LLC Stock Portfolio
DAFNA Capital Management LLC Performance:
2024 Q3: 2.74%YTD: 8.28%2023: 5.58%
Performance for 2024 Q3 is 2.74%, and YTD is 8.28%, and 2023 is 5.58%.
About DAFNA Capital Management LLC and 13F Hedge Fund Stock Holdings
DAFNA Capital Management LLC is a hedge fund based in LOS ANGELES, CA. On 30-Mar-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $542.7 Millions. In it's latest 13F Holdings report, DAFNA Capital Management LLC reported an equity portfolio of $423.3 Millions as of 30 Sep, 2024.
The top stock holdings of DAFNA Capital Management LLC are BIL, STXS, RVMD. The fund has invested 9.4% of it's portfolio in SPDR S&P BIOTECH ETF and 6.6% of portfolio in STEREOTAXIS INC.
The fund managers got completely rid off MORPHIC HOLDING INC (MORF), PROCEPT BIOROBOTICS CORP (PRCT) and SYROS PHARMACEUTICALS INC (SYRS) stocks. They significantly reduced their stock positions in ALTO NEUROSCIENCE INC, 2SEVENTY BIO INC (TSVT) and ARS PHARMACEUTICALS INC (SBTX). DAFNA Capital Management LLC opened new stock positions in LEXEO THERAPEUTICS INC, BLACK DIAMOND THERAPEUTICS I (BDTX) and BIOMX INC (PHGE). The fund showed a lot of confidence in some stocks as they added substantially to STRUCTURE THERAPEUTICS INC, ALLOGENE THERAPEUTICS INC (ALLO) and AUTOLUS THERAPEUTICS PLC (AUTL).
The top stock holdings of DAFNA Capital Management LLC are BIL, STXS, RVMD. The fund has invested 9.4% of it's portfolio in SPDR S&P BIOTECH ETF and 6.6% of portfolio in STEREOTAXIS INC.
The fund managers got completely rid off MORPHIC HOLDING INC (MORF), PROCEPT BIOROBOTICS CORP (PRCT) and SYROS PHARMACEUTICALS INC (SYRS) stocks. They significantly reduced their stock positions in ALTO NEUROSCIENCE INC, 2SEVENTY BIO INC (TSVT) and ARS PHARMACEUTICALS INC (SBTX). DAFNA Capital Management LLC opened new stock positions in LEXEO THERAPEUTICS INC, BLACK DIAMOND THERAPEUTICS I (BDTX) and BIOMX INC (PHGE). The fund showed a lot of confidence in some stocks as they added substantially to STRUCTURE THERAPEUTICS INC, ALLOGENE THERAPEUTICS INC (ALLO) and AUTOLUS THERAPEUTICS PLC (AUTL).
DAFNA Capital Management LLC Annual Return Estimates Vs S&P 500
Our best estimate is that DAFNA Capital Management LLC made a return of 2.74% in the last quarter. In trailing 12 months, it's portfolio return was 31.93%.
New Buys
| Ticker | $ Bought |
|---|---|
| lexeo therapeutics inc | 2,265,270 |
| biontech se | 1,009,540 |
| grail inc | 671,488 |
| black diamond therapeutics i | 543,750 |
| biomx inc | 409,159 |
| verastem inc | 381,823 |
New stocks bought by DAFNA Capital Management LLC
Additions
| Ticker | % Inc. |
|---|---|
| structure therapeutics inc | 580 |
| allogene therapeutics inc | 73.54 |
| polypid ltd | 66.89 |
| autolus therapeutics plc | 40.38 |
| nevro corp | 35.71 |
| mineralys therapeutics inc | 23.11 |
| blueprint medicines corp | 16.23 |
| day one biopharmaceuticals i | 12.59 |
Additions to existing portfolio by DAFNA Capital Management LLC
Reductions
| Ticker | % Reduced |
|---|---|
| alto neuroscience inc | -77.68 |
| tourmaline bio inc | -74.85 |
| mediwound ltd | -48.2 |
| 2seventy bio inc | -40.04 |
| ars pharmaceuticals inc | -38.00 |
| viking therapeutics inc | -33.58 |
| neurogene inc | -29.32 |
| larimar therapeutics inc | -22.77 |
DAFNA Capital Management LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| morphic holding inc | -7,895,650 |
| syros pharmaceuticals inc | -700,986 |
| terns pharmaceuticals inc | -585,660 |
| oric pharmaceuticals inc | -254,520 |
| procept biorobotics corp | -854,893 |
DAFNA Capital Management LLC got rid off the above stocks
Sector Distribution
DAFNA Capital Management LLC has about 74.2% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 74.2 |
| Others | 25.3 |
Market Cap. Distribution
DAFNA Capital Management LLC has about 3.8% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| MID-CAP | 29.6 |
| SMALL-CAP | 29.6 |
| UNALLOCATED | 25.9 |
| MICRO-CAP | 10.9 |
| LARGE-CAP | 3.8 |
Stocks belong to which Index?
About 51.9% of the stocks held by DAFNA Capital Management LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| RUSSELL 2000 | 50 |
| Others | 48.1 |
| S&P 500 | 1.9 |
DAFNA Capital Management LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of DAFNA Capital Management LLC
DAFNA Capital Management LLC has 83 stocks in it's portfolio. About 48.9% of the portfolio is in top 10 stocks. MRUS proved to be the most loss making stock for the portfolio. AXGN was the most profitable stock for DAFNA Capital Management LLC last quarter.
Last Reported on: 14 Nov, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ACET | adicet bio inc | 0.20 | 600,000 | 864,000 | unchanged | 0.00 | ||
| ADAP | adaptimmune therapeutics plc | 0.08 | 341,064 | 324,147 | unchanged | 0.00 | ||
| ADCT | adc therapeutics sa | 0.15 | 204,081 | 642,855 | unchanged | 0.00 | ||
| ALEC | alector inc | 1.00 | 912,928 | 4,254,240 | unchanged | 0.00 | ||
| ALKS | alkermes plc | 0.80 | 120,700 | 3,378,390 | unchanged | 0.00 | ||
| ALLO | allogene therapeutics inc | 0.70 | 1,050,120 | 2,940,330 | added | 73.54 | ||
| APRE | aprea therapeutics inc | 0.09 | 137,174 | 377,229 | unchanged | 0.00 | ||
| AQST | aquestive therapeutics inc | 0.69 | 589,561 | 2,936,010 | added | 11.24 | ||
| ARAY | accuray inc | 0.52 | 1,222,360 | 2,200,240 | unchanged | 0.00 | ||
| ATRC | atricure inc | 4.25 | 641,673 | 17,992,500 | added | 0.39 | ||
| ATXS | astria therapeutics inc | 0.66 | 254,165 | 2,798,360 | reduced | -7.29 | ||
| AUTL | autolus therapeutics plc | 0.42 | 486,667 | 1,766,600 | added | 40.38 | ||
| AXGN | axogen inc | 3.10 | 935,894 | 13,121,200 | unchanged | 0.00 | ||
| BCRX | biocryst pharmaceuticals inc | 1.20 | 667,000 | 5,069,200 | reduced | -5.32 | ||
| BCYC | bicycle therapeutics plc | 0.65 | 122,200 | 2,765,390 | unchanged | 0.00 | ||
| BDTX | black diamond therapeutics i | 0.13 | 125,000 | 543,750 | new | |||
| BIL | spdr s&p biotech etf | 9.37 | 401,505 | 39,668,700 | reduced | -9.78 | ||
| BPMC | blueprint medicines corp | 2.66 | 121,763 | 11,263,100 | added | 16.23 | ||
| CMPS | compass pathways plc | 0.36 | 243,210 | 1,532,220 | unchanged | 0.00 | ||
| CMPX | compass therapeutics inc | 0.05 | 116,882 | 215,063 | unchanged | 0.00 | ||